(Q44834251)
Statements
1 reference
Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy (English)
1 reference
Igal Kedar
1 reference
Wilmosh Mermershtain
1 reference
Hefziba Ivgi
1 reference
1 June 2004
1 reference
1 reference
110
1 reference
2
1 reference
260-265
1 reference
Identifiers
1 reference
1 reference